AT
Ahanya Thimmarayappa Nandish Kumar
About Ahanya Thimmarayappa Nandish Kumar
Data last updated:
Ahanya Thimmarayappa Nandish Kumar is a Director at Copg Global Private Limited (since 2024), Director at Indygenx Technologies Private Limited (since 2024) and Director at Capsquick Pharma Private Limited (since 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Aug 2024 | 2024 | Active | ||
| Director | 01 Jan 2024 | 2024 | Active | ||
| Director | 21 Jul 2023 | 2023 | Active |
Board colleagues of Ahanya Thimmarayappa Nandish Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nihar Kubera Naik | 10736202 | Copg Global Private Limited | Director |
| Shruthi Gladys Arokyaswamy | 10449419 | Indygenx Technologies Private Limited | Director |
| Syed Shabaz Hyder | 10248923 | Capsquick Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ahanya Thimmarayappa Nandish Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ahanya Thimmarayappa Nandish Kumar
Ahanya Thimmarayappa Nandish Kumar currently holds 3 directorships: Copg Global Private Limited (Director, since 08 Aug 2024); Indygenx Technologies Private Limited (Director, since 01 Jan 2024); Capsquick Pharma Private Limited (Director, since 21 Jul 2023).
Ahanya Thimmarayappa Nandish Kumar was first appointed on 21 Jul 2023 as Director at Capsquick Pharma Private Limited. The most recent appointment on record is 08 Aug 2024 at Copg Global Private Limited.
The current boards of Ahanya Thimmarayappa Nandish Kumar's companies include Nihar Kubera Naik (Copg Global Private Limited), Shruthi Gladys Arokyaswamy (Indygenx Technologies Private Limited), Syed Shabaz Hyder (Capsquick Pharma Private Limited).